Axio BioPharma

Madison, United States

Axio BioPharma is a CDMO using AI to accelerate the development of mammalian-expressed recombinant proteins.

$515K raised

Jan 2025

Seed

Biopharma Biotechnology Life Science Manufacturing

Top Investors

Chisos CapitalChemical Angel Network

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Axio BioPharma

How much funding has Axio BioPharma raised?

Axio BioPharma has raised $515K in total funding. The most recent round was Seed. The last funding was announced in January 2025.

Who are Axio BioPharma's investors?

Axio BioPharma's investors include Chisos Capital, Chemical Angel Network.

Where is Axio BioPharma headquartered?

Axio BioPharma is headquartered in Madison, United States.

What does Axio BioPharma do?

Axio BioPharma is a CDMO using AI to accelerate the development of mammalian-expressed recombinant proteins.

What stage is Axio BioPharma at?

Axio BioPharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2025.

MLA

"Axio BioPharma — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/axio-biopharma. Accessed June 8, 2026.

APA

VCBacked. (2025). Axio BioPharma — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/axio-biopharma

Wikipedia (cite web)

{{cite web |title=Axio BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/axio-biopharma |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2025.

Similar Companies in Biopharma